HC ADVISORS, LLC – Celldex Therapeutics, Inc. Transaction History
HC ADVISORS, LLC portfolio value:
$341,000
portfolio value
HC ADVISORS, LLC quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +59.15% | 4.51K shares | 135K | $28.11 | 12.13K |
| Q2 2022 | share | Decrease | -0.65% | -50 shares | -55K | $26.96 | 7.62K |
| Q1 2022 | share | Decrease | -6.21% | -508 shares | -55K | $34.06 | 7.67K |
| Q4 2021 | share | Increase | +49.08% | 2.69K shares | 20K | $38.9 | 8.18K |
| Q3 2021 | share | Decrease | -14.45% | -927 shares | 81K | $53.99 | 5.48K |
| Q2 2021 | share | Increase | 0.00% | 6.41K shares | 215K | $33.44 | 6.41K |
| Q1 2021 | share | Decrease | -100.00% | -14.79K shares | -259K | $20.6 | 0 |
| Q4 2020 | share | Increase | +17.57% | 2.21K shares | 72K | $17.52 | 14.79K |
| Q3 2020 | share | Increase | 0.00% | 12.58K shares | 187K | $14.83 | 12.58K |